Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PreveCeutical Medical ( (TSE:PREV) ) just unveiled an update.
PreveCeutical Medical Inc. has appointed Dr. Bryan Jones as an advisor to lead Sol-Gel Special Projects, effective January 31, 2025. Dr. Jones, with over 30 years of experience in drug development, is expected to advance the company’s Sol-Gel program aimed at delivering therapeutics from nose to brain, accelerating its development and potentially enhancing the company’s position in the health sciences sector.
More about PreveCeutical Medical
PreveCeutical Medical Inc. is a health sciences company that develops innovative preventive and curative therapies using organic and nature-identical products.
YTD Price Performance: -16.67%
Average Trading Volume: 123,390
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $11.25M
For a thorough assessment of PREV stock, go to TipRanks’ Stock Analysis page.